The Phoenix ED Device Lawsuit: Allegations, Status, and Eligibility

The Phoenix ED device lawsuit is an active consumer fraud case alleging that DesireHealth sold its roughly $879 to $999 home-use acoustic wave device with deceptive claims that it is “clinically proven” to treat erectile dysfunction, when the device lacks FDA clearance for ED and the studies cited in its marketing were run on professional-grade equipment rather than the Phoenix itself.¹ The case is in discovery as of mid-2026, no settlement exists, and a ruling on whether it can proceed as a class action is expected in mid-2026.

What the Lawsuit Alleges

The core claim is false advertising, breach of warranty, and violations of state consumer protection laws. Plaintiffs argue that DesireHealth built a nearly $1,000 product around evidence that doesn’t apply to it.¹

Four specific allegations drive the case:

Marketing cited clinical studies conducted with professional, office-based shockwave equipment rather than the Phoenix, giving the impression the consumer device had been tested and proven.¹
The Phoenix does not hold FDA clearance for treating ED, and no shockwave device of any kind is FDA-cleared for that indication, yet promotional materials allegedly implied clearance or failed to disclose the gap.²
Testimonials featured in marketing did not represent typical consumer results.¹
The device was called “clinically proven” for at-home use despite no independent trials evaluating the consumer product.¹

The evidentiary backbone is a large volume of consumer grievance. More than 500 complaints were filed with the Better Business Bureau against DesireHealth over a two-year period, with recurring themes of ineffectiveness, difficulty getting refunds, and unresponsive customer service. Many users reported completing the recommended 60- to 90-day protocol with no improvement.¹³ Plaintiffs’ attorneys are using that volume and consistency to argue systemic harm rather than isolated dissatisfaction, which is central to class certification.

Some consumers have also reported localized pain, skin irritation, bruising, and worsening symptoms. Physical harm isn’t the primary legal theory, but plaintiffs point to it as further evidence the device was not validated for unsupervised consumer use.¹

Why the Science Claims Are Contested

Low-intensity extracorporeal shockwave therapy, or Li-ESWT, has genuine clinical support when administered with professional equipment in a clinical setting. A 2024 umbrella review of 25 randomized controlled trials found statistically significant improvements in erectile function scores compared to placebo.⁴ A 2022 review in American Family Physician reached a similar conclusion.⁵

Those studies, however, used medical-grade devices with calibrated energy output and pulse counts of roughly 1,500 to 5,000 per session, delivered by trained clinicians.⁴ No published study has evaluated a self-administered home device like the Phoenix.⁶ Clinicians have noted that at-home devices “vary dramatically” from FDA-approved clinical equipment and may not deliver enough energy to produce the effects seen in trials.⁷

Professional bodies have taken a cautious position. The American Urological Association classifies shockwave therapy for ED as “investigational” and recommends limiting it to research settings, and the Sexual Medicine Society of North America has taken a similar stance.² No shockwave device, professional or consumer, has received FDA clearance to treat erectile dysfunction.⁸

Where the Case Stands Now

The litigation began between 2023 and 2024 and remains active. Plaintiffs’ attorneys filed updated briefs in late 2025 focused on DesireHealth’s online marketing language, testimonial videos, and product documentation.¹ Discovery requests target the company’s internal marketing research and any FDA correspondence.

Related claims from different plaintiffs have been consolidated under one lead counsel team, and the immediate question is class certification. A ruling is expected in mid-2026. DesireHealth is opposing certification, arguing that consumer experiences with the device vary too widely to meet the commonality and typicality requirements.¹

If certification is granted, the case can move toward settlement negotiations. If denied, plaintiffs may appeal or pursue individual claims. Consumer fraud class actions of this scale typically take 18 to 36 months to resolve, placing any potential outcome between late 2026 and 2027.¹

Who May Be Eligible

No settlement exists yet, so there is no claims form to file and no payout available. If the case is certified and a settlement is reached, legal observers estimate individual payouts in comparable consumer class actions typically fall between $50 and $500 per claimant, depending on the documentation each person can produce. Attorney fees in class actions this size generally run 25% to 33% of the total fund.¹

The current eligibility criteria track the scope of the litigation:

You purchased a Phoenix Pro or a related DesireHealth shockwave device after January 2020.
You are a U.S. resident.
You have documentation of the purchase or evidence of dissatisfaction with the device’s performance.

Physical injury isn’t required. The financial harm of paying for a product that didn’t perform as advertised is a recognized legal injury in consumer fraud cases. If you think you may qualify, hold on to receipts, credit card statements, and any correspondence with DesireHealth. Filing complaints with the BBB, the Federal Trade Commission, or your state attorney general adds to the broader evidentiary record.¹

Who Makes the Device

The Phoenix is sold by Launch Medical, a Scottsdale, Arizona company operating under the DesireHealth brand in this litigation. Its BBB profile carries an A+ organizational rating alongside a consumer review score of 2.5 out of 5, with negative reviews concentrated on the device failing to produce promised results.⁶ The device was originally sold under the name “The Rocket” before being rebranded following an earlier legal dispute.⁹

1
LawFold. The Phoenix ED Device Lawsuit
2
Empire Medical Training. Shockwave Therapy for ED
3
Lawsuit Talks. The Phoenix ED Device Lawsuit
4
National Institutes of Health. Li-ESWT for Vascular Erectile Dysfunction: An Umbrella Review
5
American Academy of Family Physicians. Shockwave Therapy for Erectile Dysfunction
6
Innerbody. Phoenix ED Device Reviews
7
Dr. Kate Kass. At-Home Shockwave Therapy for ED: Is It Effective
8
Newswise. Shockwave Therapy for Erectile Dysfunction: Concerns Raised About Marketing of Unproven Therapy
9
Our Ventura Blvd. Launch Medical